0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Invited Critique |

Invited Critique: Surgical Treatment of Hydatid Disease of the Liver

Kazutomo Inoue, MD
Arch Surg. 1999;134(2):169. doi:10.1001/archsurg.134.2.169.
Text Size: A A A
Published online

Extract

This article represents a retrospective study on the results of different modalities of treatment of hydatid disease of the liver, concluding that capitonnage, omentoplasty, cystectomy, lobectomy, and cystoenterostomy are superior to tube drainage and that marsupialization or tube drainage should be avoided as much as possible. Human hydatid disease, an endemic disease in many countries, is caused by a parasite that is identified as Echinococcus granulosus or Echinococcus multilocularis. Most of the embryos are trapped in the liver and the rest pass through the liver and are scattered to other organs such as the lung, brain, or spleen, where they develop into hydatid cysts. Although the proliferation and differentiation of germinal cells of E multilocularis are presumed to be deeply involved in the incidence of this disease, the clinocopathologic features of the disease are not well established. Chemotherapy is reportedly not effective in most cases.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();